September 18, 2025
Image source: Adobe Stock
In a surprising announcement that finds two long-time rivals working together, Nvidia and Intel announced today that the companies would jointly develop multiple new generations of x86 products together.
The products include x86 Intel CPUs tightly fused with an Nvidia RTX graphics chiplet for the consumer gaming PC market, named the ‘Intel x86 RTX SOCs.’
Nvidia will also have Intel build custom x86 data center CPUs for its AI products for hyperscale and enterprise customers.
Nvidia also announced that it will buy $5 billion in Intel common stock at $23.28 per share. Tom’s Hardware reports.
🤖 Meta launches $799 glasses with screen and AI integration
Meta Platforms, seeking to turn its smart glasses lineup into a must-have product, on Wednesday unveiled its first version with a built-in screen.
The latest model, the $799 Meta Ray-Ban Display, features a screen in the right lens. It can show text messages, video calls, turn-by-turn directions in maps and visual results from queries to Meta’s AI service.
The subtly integrated display can also serve as a viewfinder for the camera on a user’s phone or surface music playback. Yahoo Finance reports.
💊 Novo Nordisk shares pop 5% after Wegovy pill trial shows ‘significant’ weight reduction
Novo Nordisk have announced that late-stage trial results for its once-daily obesity pill showed “significant” weight reduction and tolerability in line with its blockbuster Wegovy injection, as drugmakers race to get an oral treatment to market.
Results from the phase 3 Oasis 4 trial showed the oral semaglutide pill led to average weight reduction of 16.6% after 64 weeks in patients with obesity or overweight and at least one weight-related comorbidity, the Danish pharmaceutical firm said. Shares jumped 5.4% in pre-market trading. CNBC reports.
📊 DuPont cuts third-quarter profit forecast
DuPont said on Thursday it has cut its third-quarter adjusted profit forecast to reflect the impact of reclassifying its heat resistant fiber brand, Aramids, as discontinued operations.
It expects adjusted profit of $1.06 per share for the third quarter, compared with its earlier forecast of $1.15 per share. MarketScreener reports.
🏛️ Fed: the doves have gone to roost
Unsurprisingly, the Fed lowered its rates by 25 basis points yesterday. This decision was more consensual than expected, as only Stephen Miran, the new governor still employed by the White House, backed a 50 basis point cut.
However, many expected several members to oppose the decision. And potentially in both directions. Some in favor of larger reductions; others in favor of the status quo.
In particular, the markets expected dissenting votes from Christopher Waller and Michelle Bowman, who had already voted against the status quo at the July meeting (they wanted a quarter-point cut). Even Stephen Miran remained relatively moderate, voting for a 50bp cut, while his boss wanted 100-to-150bp immediately. MarketScreener reports.
💻 Huawei unveils AI chip roadmap to challenge Nvidia’s lead
Huawei Technologies Co. unveiled new technology from memory chips to AI accelerators Thursday, outlining publicly for the first time its multiyear plan to challenge Nvidia Corp.’s dominance in a growing market.
The highlight of the company’s presentation on Thursday were new SuperPod cluster designs that will allow Huawei to link as many as 15,488 of its Ascend neural processing units for artificial intelligence and operate them as a coherent system, rotating chairman Eric Xu said at the event.
Those SuperPod products will be built with new generations of Ascend chips from next year. Yahoo Finance reports.
(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM Eastern Time)
Benzinga reports.
1) $ETNB: 89bio
Total gain: +83.78%
2) $APVO: Aptevo Therapeutics
Total gain: +79.43%
3) $AQB: AquaBounty Techs
Total gain: +52.63%
4) $PBM: Psyence Biomedical
Total gain: +39.24%
5) $ATCH: AtlasClear Holdings
Total gain: +22.83%
The closing price of the top three market percent gainers trading near or above $3 on September 17.
Benzinga reports.
*All pricing and percent gains are based on regular market trading hours from 9:30am to 4:00pm Eastern Time
1) SPRC: SciSparc
Total gain: +138.85%
The stock appeared to be moving on no notable news.
2) SQFT: Presidio Property Trust
Total gain: +47.28%
The stock appeared to be moving on no notable news.
3) QMMM: QMMM Holdings
Total gain: +30%
The stock appeared to be moving on no notable news.
*Estimate and Actual numbers represent Earnings Per Share in US Dollars
FDS: FactSet Research Systems
Q4 2025
Before Market Open
Estimate: 4.140
Actual: 4.050
FDX: FedEx
Q1 2026
After Market Close
Estimate: 3.630
Actual: N/A
LEN: Lennar
Q3 2025
After Market Close
Estimate: 2.100
Actual: N/A
Time (ET) | Report | Period
8:30 AM - Initial jobless claims - September
8:30 AM - Philadelphia Fed manufacturing survey - September
10:00 AM - U.S. leading economic indicators - August
“Know what you own, and know why you own it.”
- Peter Lynch
Sourced in: “Investopedia”.
TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas; and TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of the Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF) (collectively the "TradeZero Broker Dealers”) are subsidiaries of TradeZero Holding Corp.
TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference. There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors only as the amount you may lose can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses. Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the options disclosure (ODD) at OCC before deciding to engage in options trading.
If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.